HealthDay - FRIDAY, Nov. 20 (HealthDay News) -- For the second time in a week, medical experts are revising the advice given women on cancer screenings.

AP - First mammograms. Now — in an apparent coincidence — Pap smears.

Reuters - Women in the United States should start cervical cancer screening at age 21 and most do not need an annual Pap smear, according to new guidelines issued on Friday that aim to reduce the risk of unnecessary treatment.

HealthDay - WEDNESDAY, Nov. 18 (HealthDay News) -- Herpes, the sexually transmitted disease that causes genital lesions, never truly goes into a dormant state, new research suggests.

AP - Sexually spread diseases continue to rise, with reported chlamydia cases setting yet another record in 2008, government health officials said Monday.

Reuters - A once-daily pill developed by Germany's Boehringer Ingelheim increased female sex drive in late-stage trials, putting the group in the frame to launch the first non-hormonal treatment for women with low libido.

Reuters - American squeamishness about talking about sex has helped keep common sexually transmitted infections far too common, especially among vulnerable teens, U.S. researchers reported Monday.

HealthDay - WEDNESDAY, Nov. 4 (HealthDay News) -- A vaccine that targets human papillomavirus (HPV) is able to stop precancerous lesions in the vulva from progressing into full-blown malignancies, Dutch researchers report.

HealthDay - TUESDAY, Oct. 27 (HealthDay News) -- Traditional Pap tests and the newer liquid-based cytology are equally reliable in screening for cervical cancer, a new study has found.

HealthDay - WEDNESDAY, Oct. 21 (HealthDay News) -- A U.S. advisory panel on Wednesday voted against the routine use of the vaccine Gardasil in boys and men, but did leave individual doctors free to recommend the vaccine for males as an option.

Reuters - U.S. vaccine advisers declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead on Wednesday to simply advise doctors they are free to use it.

AP - A second kind of vaccine against cervical cancer may be added to the recommended list for girls and young women after a federal advisory panel voted Wednesday to support it.

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - FRIDAY, Oct. 16 (HealthDay News) -- GlaxoSmithKline's Cervarix vaccine has been approved by the U.S. Food and Drug Administration to prevent the leading cause of cervical cancer, the Associated Press reported Friday.

Reuters - GlaxoSmithKline Plc won U.S. approval on Friday to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males.

HealthDay - THURSDAY, Oct. 15 (HealthDay News) -- New cases of genital warts have declined sharply since vaccination of teen girls and young women against the human papillomavirus (HPV) began in Australia in 2007, a new study has found.

HealthDay - THURSDAY, Oct. 8 (HealthDay News) -- The cost of giving boys the human papillomavirus (HPV) vaccine would outweigh any health benefit, researchers say.

HealthDay - FRIDAY, Oct. 9 (HealthDay News) -- Human papillomavirus (HPV) appears to be linked to an increase in cases of a rare type of head and neck cancer, a new study has found.